Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 8/20 | 0.38 |
| ▸ | HTR2C | P28335 | 8/20 | 0.38 |
| ▸ | HTR2B | P41595 | 4/20 | 0.34 |
| ▸ | USP1 | O94782 | 3/20 | 0.32 |
| ▸ | HTR1A | P08908 | 2/20 | 0.30 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.30 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.30 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.30 |
| ▸ | HTR1D | P28221 | 1/20 | 0.30 |
| ▸ | HTR7 | P34969 | 1/20 | 0.30 |
| ▸ | HTR4 | Q13639 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18898669 | 0.82 | XDH (0.36) | HTR2AHTR2CHTR2B | |
| SCHEMBL25164185 | 0.81 | HTR2A (0.34) | HTR2AHTR2CHTR2BUSP1 | |
| SCHEMBL25164210 | 0.80 | CYP17A1 (0.38) | HTR2AHTR2CUSP1 | |
| SCHEMBL25164208 | 0.79 | RIPK1 (0.37) | HTR2AHTR2CUSP1 | |
| SCHEMBL29202302 | 0.78 | HTR2A (0.33) | HTR2AHTR2CHTR2B | |
| SCHEMBL30328297 | 0.78 | HTR2A (0.33) | HTR2AHTR2CHTR2B | |
| SCHEMBL25164322 | 0.75 | PDE10A (0.33) | — | |
| SCHEMBL19421539 | 0.73 | PI4KA (0.34) | — | |
| SCHEMBL17807781 | 0.71 | AURKA (0.40) | — | |
| SCHEMBL30174416 | 0.71 | HTR2A (0.40) | HTR2AHTR2CHTR2BHTR1AADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023064343-A1 | SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND USES THEREOF | VANQUA BIO, INC. (US) | 2023-04-20 | — | — | WO | disclosed |